Lentiviral vector-mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo

Tumor Biology

Volumn 27, Issue 5, 2006, Pages 243-251

  Chi, Weiling ^a,b   Song, Xianrang ^a,b   Jiang, Chunying ^b   Liu, Xianxi ^a   Li, Wentong ^a   Wang, Xingwu ^b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cell proliferation; Colorectal cancer; Lentiviral vector; Ornithine decarboxylase; RNA interference

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; ORNITHINE DECARBOXYLASE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; WESTERN BLOTTING; XENOGRAFT;

EID: 33747476469     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094843     Document Type: Article

References (34)

1. Pegg AE, Feith DJ, Fong LY, et al: Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem Soc Trans 2003;31:356-360.
2. Ramesh MB, Barbar JZ, Shirley AM, et al: Polyamine depletion arrests cell cycle and induces inhibitors p21 Waf1/Cip1, p27Kip1, and p53 in IEC-6 cells. Am J Physiol Cell Physiol 1999;276:684-691.
3. Kubota S, Kiyosawa H, Nomura Y, et al: Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. J Natl Cancer Inst 1997;89:567-571.
4. Auvinen M, Paasinen A, Andersson LC, et al: Ornithine decarboxylase activity is critical for cell transformation. Nature 1992;360:355-358.
5. Auvinen M, Laine A, Paasinen A, et al: Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 1997;57:3016-3025.
6. Thomas T, Thomas TJ: Polyamine in cell growth and cell death: molecular mechanism and therapeutic applications. Cell Mol Life Sci 2001;58:244-258.
7. Gerner EW, Meyskens FL Jr: Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004;4:781-792.
8. Martínez ME, O'Brien TG, Fultz KE, et al: Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci USA 2003;100:7859-7864.
9. Faaland CA, Thomas TJ, Balabhadrapathruni S, et al: Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. Biochem Cell Biol 2000;78:415-426.
10. Meyskens FL, Gerner EW: Development of α-difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999;5: 945-951.
11. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296: 550-553.
12. Chi WL, Liu XX, Song XR, et al: Construction and identification of the lentiviral RNA interference vector of human ODC gene. J Shandong Univ 2005;43:199-202.
13. Wei MQ, Wang JP, Xia HQ, et al: Atrial natriuretic peptide gene transfer and regulated expression in primary vascular smooth muscle cells. Gene Ther Regul 2001;1:265-284.
14. Zhang B, Metharom P, Jullie H, et al: The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for prediction gene transfer events. Genet Vaccines Ther 2004;2:6.
15. Bernard PS, Wittwer CT: Real-Time PCR technology for cancer diagnostics. Clin Chem 2002;48:1178-1185.
16. Todd R, McBride J, Tsuji T, et al: Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 1995;9:1362-1370.
17. Czauderna F, Santel A, Hinz M: Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res 2003; 21:127-133.
18. Coffino P, Poznanski A: Killer polyamines? J Cell Biochem 1991;45:54-58.
19. Coffino P: Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2001;2: 188-194.
20. Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995;35:55-91.
21. Gandre S, Bercovich Z, Kahana C: Ornithine decarboxylase-antizyme is rapidly degraded through a mechanism that requires functional ubiquitin-dependent proteolytic activity. Eur J Biochem 2002;269:1316-1322.
22. Milovic V, Turchanowa L: Polyamines and colorectal cancer. Biochem Soc Trans 2003;31: 381-383.
23. Wallace HM, Caslake R: Polyamines and colorectal cancer. Eur J Gastroenterol Hepatol 2001;13:1033-1039.
24. McCormack SA, Johnson LR: Polyamines and cell migration. J Physiol Pharmacol 2001;52: 327-349.
25. Clayton J: The silent treatment. Nature 2004; 431:599-605.
26. Zhang XN, Xiong W, Wang JD, et al: siRNA-mediated inhibition of HBV replication and expression. World J Gastroenterol 2004;10: 2967-2971.
27. Crystal RG: Transfer of genes to humans: early lessons and obstacles to success. Science 1995;270:404-410.
28. Brummelkamp TR, Bernards R, Agami R: Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2: 243-247.
29. Rubinson DA, Dillon CP, Kwiatkowski AV, et al: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-406.
30. Paddison PJ, Caudy AA, Hannon GJ: Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA 2002;99:1443-1448.
31. McCormack SA, Blanner PM, Zimmerman BJ, et al: Polyamine deficiency alters EGF receptor distribution and signal effectiveness in IEC-6 cells. Am J Physiol 1998;274:C192-C205.
32. Kip1, and p53 in IEC-6 cells. Am J Physiol Cell Physiol 1999;276:C684-C691.
33. Clifford A, Morgan D, Yuspa SH, et al: Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 1995;55:1680-1686.
34. Lan L, Trempus C, Gilmour SK: Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice. Cancer Res 2000;60:5696-5703.